profit from every HK$100 of sales.
HK$0HK$100
WuXi AppTec
HK$191.60-4.87% today
+82.3% in 1 year
1-year low HK$99.001-year high HK$218.60
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay HK$25.82 for every HK$1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What WuXi AppTec sold, what it kept, and what it did with the cash.
Sales went from CN¥39.4 billion in 2022 to CN¥45.5 billion in 2025, with CN¥19.2 billion of profit last year.
SalesProfit
WuXi AppTec handed back 43% of the cash it generated last year.
CN¥5.0B
Free cash flow 2025CN¥11.7B
Bought back its own shares–
Paid as dividendsCN¥5.0B
Cash vs. debtCN¥35.1B vs. CN¥8.4B
WuXi AppTec vs. similar companies
WuXi AppTec grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from HK$100 of sales | Sales growth a year | Price per HK$1 of profit |
|---|---|---|---|
| WuXi AppTec | 25.8× · Fair price | ||
 Thermo Fisher Scientific | 38.7× · Expensive | ||
 Danaher | 45.4× · Expensive | ||
 Waters | 140.8× · Very expensive | ||
 Lonza Group | No profit yet |
AI analysis
An AI analyst reads WuXi AppTec's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CNY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 39,355 | 40,341 | 39,241 | 45,456 | |
| 14,678 | 16,612 | 16,277 | 21,655 | |
| 9,748 | 11,766 | 11,612 | 17,005 | |
| 12,472 | 14,309 | 14,591 | 27,687 | |
| 8,814 | 9,607 | 9,450 | 19,151 | |
| 2.82 | 3.24 | 3.26 | 6.61 | |
| 37.3% | 41.2% | 41.5% | 47.6% | |
| 24.8% | 29.2% | 29.6% | 37.4% | |
| 22.4% | 23.8% | 24.1% | 42.1% |
Balance sheet
| In millions of CNY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 64,690 | 73,669 | 80,326 | 103,121 |
| Cash | 7,986 | 13,764 | 18,322 | 35,131 |
| Total debt | 5,866 | 5,748 | 5,009 | 8,420 |
| Total liabilities | 17,764 | 18,152 | 21,240 | 22,873 |
| 46,590 | 55,122 | 58,633 | 79,712 | |
| 3,125 | 2,965 | 2,899 | 2,897 | |
| 17.2% | 16.5% | 15.5% | 22.9% | |
| 18.9% | 17.4% | 16.1% | 24.0% |
Cash flow
| In millions of CNY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 10,616 | 13,387 | 12,407 | 17,203 | |
| 9,966 | 5,517 | 4,003 | 5,538 | |
| 650 | 7,870 | 8,403 | 11,665 | |
| Dividends paid | 1,598 | 2,756 | 3,085 | 4,969 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 25.8×
- –
- 0.79
- 4.6×
- 10.9×
- 42.4×
- 16.9×
- 2.4%
- 3.9%
- 1.0%
Profitability
- 47.6%
- 37.4%
- 42.1%
- –
- 22.9%
- 18.0%
- –
- –
- –
- –
Growth
- +4.9%
- +32.8%
- –
- –
- −2.5%
Financial health
- -1.0×
- 0.11
- –
- 79.0×
- 3.21
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 6%of 946
Top 6%of 872
Top 44%of 564
Bottom 27%of 867
Top 39%of 986
1.0%of the share price, paid each year
On $1,000 invested$10a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
25.9% of its profit
Room to growStretchedMore than it earns: 42.6%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
6/7Passes 6 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
75Pass
Benjamin Graham
64Pass
Philip Fisher
84Pass
Peter Lynch
91Pass
Joel Greenblatt
44No pass
Charlie Munger
84Pass
Terry Smith
70Pass
Questions about WuXi AppTec
Is WuXi AppTec a good stock to buy?
A strong, very profitable business at a fair price. 6 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the WuXi AppTec AI analysis
What does WuXi AppTec do?
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. It is in Diagnostics & Research, based in Shanghai, China, with 33,834 employees.
Does WuXi AppTec pay a dividend?
Yes. At today's price the dividend is 1.0% a year, about 26% of its yearly profit. In 2025 it paid out HK$4.97 billion in dividends.
Is WuXi AppTec stock halal?
Yes. WuXi AppTec passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has WuXi AppTec stock done over the past year?
Up 82.3% over the past twelve months, to HK$191.60. It traded between HK$99.00 and HK$218.60 and is 12.4% below its high.
Who are WuXi AppTec's competitors?
The largest listed companies in the same industry are Thermo Fisher Scientific, Danaher, Waters and Lonza Group. The peers table on this page compares their profit, growth and price with WuXi AppTec's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.